Atlas Trials

Colistin-rifampin Combination and Colistin Monotherapy in Extensively Drug-resistant Acinetobacter Baumannii

Clinical trial NCT03622918 · COMPLETED

Trial details

NCT number
NCT03622918
Sponsor
Gangnam Severance Hospital
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
ColistinRifampinAcinetobacter Infections
Start date
2016-10-27
Primary completion
2017-09-24
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.